FDA Approves New HIV Drug for Adults with Limited Treatment Options
U.S. Food and Drug Administration
The new medication is for those whose HIV infections cannot be successfully treated with other treatments
HIV Research
Encouraging Findings in First-in-Human Clinical Trial Evaluating HIV Vaccine
The Scripps Research Institute
Scripps Research publish study data in Science, helping validate novel vaccination strategy
COVID-19 Disruptions in HIV Testing, Prevention Highlight Need for Innovation
Centers for Disease Control and Prevention
The rapid rebound in services, if scaled up, could help reach national prevention goals
A Better Understanding of How HIV-1 Evades the Immune System
University of Montreal
The expression of Vpu helps infected cells evade the ADCC elimination method
Early HIV Diagnosis and Treatment Important for Better Health Outcomes
National Institutes of Health
Findings based on an extended follow-up of participants in the START study
Three-Dose Hepatitis B Vaccine Regimen Protects People with HIV
National Institutes of Health
Findings presented at IDWeek conference is part of an ongoing clinical trial
Ethics Not Only Allow but Demand Placebo in Some HIV Cure Trials
Rutgers University
Ethicists argue for the ethics of stopping antiretroviral treatment for patients who receive a placebo
Hope for HIV Cure from Cord Blood Stem Cell Transplant Study
Zahraa Chorghay, PhD
The third known case of HIV remission in an individual with stem cell transplant offers clues for HIV cure
Discovery of New Highly Virulent and Damaging HIV Variant in the Netherlands
University of Oxford
New HIV variant with higher virulence and more damaging health impacts discovered
Treating Anal Cancer Precursor Lesions Reduces Cancer Risk for People with HIV
University of California - San Francisco
Groundbreaking national clinical trial halted due to therapy’s high success rates